These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19827052)

  • 1. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks.
    Poon LC; Karagiannis G; Leal A; Romero XC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):497-502. PubMed ID: 19827052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.
    Poon LC; Stratieva V; Piras S; Piri S; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):216-23. PubMed ID: 20108221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks.
    Poon LC; Staboulidou I; Maiz N; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Aug; 34(2):142-8. PubMed ID: 19644947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.
    Poon LC; Akolekar R; Lachmann R; Beta J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):662-70. PubMed ID: 20232288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure.
    Onwudiwe N; Yu CK; Poon LC; Spiliopoulos I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Dec; 32(7):877-83. PubMed ID: 18991324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy screening for hypertensive disorders in women without a-priori high risk.
    Abdelaziz A; Maher MA; Sayyed TM; Bazeed MF; Mohamed NS
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):398-405. PubMed ID: 22689569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia.
    Plasencia W; Maiz N; Poon L; Yu C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Aug; 32(2):138-46. PubMed ID: 18634131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in uterine artery Doppler and blood pressure and risk of pre-eclampsia.
    Khalil A; Garcia-Mandujano R; Maiz N; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2014 May; 43(5):541-7. PubMed ID: 24265180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal venous Doppler characteristics are abnormal in pre-eclampsia but not in gestational hypertension.
    Gyselaers W; Staelens A; Mesens T; Tomsin K; Oben J; Vonck S; Verresen L; Molenberghs G
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):421-6. PubMed ID: 24890401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 11-13 weeks.
    Poon LC; Kametas NA; Valencia C; Chelemen T; Nicolaides KH
    Hypertens Pregnancy; 2011; 30(1):93-107. PubMed ID: 20818956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
    Tayyar A; Garcia-Tizon Larroca S; Poon LC; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):18-27. PubMed ID: 24970282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine artery Doppler at 30-33 weeks' gestation in the prediction of preeclampsia.
    Lai J; Poon LC; Pinas A; Bakalis S; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):156-63. PubMed ID: 23445882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OS088. First trimester triple vascular test for pre-eclampsia prediction.
    Alves JA; Brennecke SP; da Silva Costa F
    Pregnancy Hypertens; 2012 Jul; 2(3):226. PubMed ID: 26105303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.
    Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.